RxTrials and Integra Clinical Research will form a strategic partnership to enhance their capacity to conduct clinical research. RxTrials conducts phase II through phase IV and vaccine clinical research studies while Integra focuses on neurological diseases.
Under the agreement, Integra, based in San Antonio, will become an RxTrials partner research site. RxTrials, headquartered in Ellicott City, Maryland, has ten research sites in five states.
"We have conducted CNS research for the past 12 years," said Suzanne K. Gazda, M.D., CEO and principal investigator at Integra.
"We have every confidence our association with RxTrials with their experience, leadership, oversight and key relationships within the research industry will further our mission of providing a high-quality process and product," said Gazda.